We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$47.3B
AUM Growth
+$3.18B
Cap. Flow
+$116M
Cap. Flow %
0.24%
Top 10 Hldgs %
11.39%
Holding
2,836
New
148
Increased
1,004
Reduced
1,103
Closed
268

Top Buys

Rank Stock Value
1
ABNB icon
Airbnb
ABNB
+$541M
2
QCOM icon
Qualcomm
QCOM
+$532M
3
CVX icon
Chevron
CVX
+$514M
4
COP icon
ConocoPhillips
COP
+$495M
5
COR icon
Cencora
COR
+$473M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$559M
2
GILD icon
Gilead Sciences
GILD
+$542M
3
LNG icon
Cheniere Energy
LNG
+$523M
4
LYB icon
LyondellBasell Industries
LYB
+$457M
5
VTRS icon
Viatris
VTRS
+$441M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.84%
2 Technology 17.7%
3 Energy 16.46%
4 Industrials 10.01%
5 Healthcare 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCC
1351
CCC Intelligent Solutions
CCC
$3.5B
– –
-75,308
Closed -$837K
CCCC icon
1352
C4 Therapeutics
CCCC
$397M
– –
-1,056
Closed -$4.88K
CDNA icon
1353
CareDx
CDNA
$1.88B
– –
-509
Closed -$7.91K
CGEM icon
1354
Cullinan Oncology
CGEM
$1.07B
– –
-595
Closed -$10.4K
CGON icon
1355
CG Oncology
CGON
$6.48B
– –
-290
Closed -$9.15K
CLDX icon
1356
Celldex Therapeutics
CLDX
$2.8B
– –
-680
Closed -$25.2K
COGT icon
1357
Cogent Biosciences
COGT
$6.91B
– –
-1,046
Closed -$8.82K
CRBP icon
1358
Corbus Pharmaceuticals
CRBP
$168M
– –
-132
Closed -$5.97K
CRGX
1359
DELISTED
CARGO Therapeutics
CRGX
– –
-230
Closed -$3.78K
CRNX icon
1360
Crinetics Pharmaceuticals
CRNX
$8.87B
– –
-638
Closed -$28.6K
CRSP icon
1361
CRISPR Therapeutics
CRSP
$4.6B
– –
-1,038
Closed -$56.1K
CVCO icon
1362
Cavco Industries
CVCO
$4.46B
– –
-203,662
Closed -$70.5M
CVNA icon
1363
Carvana
CVNA
$45.9B
– –
-1,565
Closed -$40.3K
DAWN
1364
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-851
Closed -$11.7K
DIN icon
1365
Dine Brands
DIN
$448M
– –
-1,343
Closed -$48.6K
DNLI icon
1366
Denali Therapeutics
DNLI
$3.74B
– –
-862
Closed -$20K
DYN icon
1367
Dyne Therapeutics
DYN
$4.24B
– –
-827
Closed -$29.2K
EBS icon
1368
Emergent Biosolutions
EBS
$378M
– –
-75
Closed -$512
EDIT icon
1369
Editas Medicine
EDIT
$411M
– –
-1,222
Closed -$5.71K
EEM icon
1370
iShares MSCI Emerging Markets ETF
EEM
$28.6B
– –
-45,000
Closed -$1.92M
ENR icon
1371
Energizer
ENR
$1.44B
– –
-98
Closed -$2.9K
ETNB
1372
DELISTED
89bio
ETNB
– –
-816
Closed -$6.54K
EWT icon
1373
iShares MSCI Taiwan ETF
EWT
$9.99B
– –
-212
Closed -$11.5K
EXAS
1374
DELISTED
Exact Sciences
EXAS
– –
-2,517
Closed -$106K
FATE icon
1375
Fate Therapeutics
FATE
$283M
– –
-1,426
Closed -$4.68K
53 54
55
56 57

Similar funds

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Pacer Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Pacer Advisors held 2,836 positions worth $47.3B, up 7.2% from $44.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pacer Advisors's Q3 2024 filing shows 148 new, 1,004 increased, 1,103 reduced and 268 closed positions. Its largest new stake was TechnipFMC: 7,077,502 shares worth $186M. The largest sale was 3M, an estimated $559M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Technology and Energy.

  • Pacer Advisors's largest Q3 2024 buy was TechnipFMC: 7,077,502 shares worth $186M.
  • Pacer Advisors added most to Airbnb in Q3 2024, an estimated $541M increase.
  • Pacer Advisors's biggest Q3 2024 reduction was 3M, cutting an estimated $559M.
  • Pacer Advisors fully exited Newell Brands in Q3 2024, selling an estimated $301M.
  • Pacer Advisors's ten largest holdings make up 11% of its $47.3B portfolio in Q3 2024.
  • Pacer Advisors opened 148 new positions and closed 268 in Q3 2024.
  • Pacer Advisors's portfolio value rose 7.2% quarter-over-quarter to $47.3B.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.